Location of Inhibitor Binding Sites in the Human Inducible Prostaglandin E Synthase, MPGES1

被引:28
|
作者
Prage, Edward B. [1 ,2 ,3 ]
Pawelzik, Sven-Christian [4 ]
Busenlehner, Laura S. [1 ,2 ,3 ]
Kim, Kwangho [5 ,6 ]
Morgenstern, Ralf [7 ]
Jakobsson, Per-Johan [4 ]
Armstrong, Richard N. [1 ,2 ,3 ]
机构
[1] Vanderbilt Univ, Ctr Mol Toxicol, Dept Chem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Ctr Mol Toxicol, Dept Biochem, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA
[4] Karolinska Inst, Rheumatol Unit, Dept Med, S-17176 Stockholm, Sweden
[5] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA
[6] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Pharmacol, Nashville, TN 37235 USA
[7] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
STRUCTURAL BASIS; E-2; SYNTHASE; EXCHANGE; IDENTIFICATION; DYNAMICS; ENZYME;
D O I
10.1021/bi2010448
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The inducible microsomal prostaglandin E-2 synthase 1 (MPGES1) is an integral membrane protein coexpressed with and functionally coupled to cyclooxygenase 2 (COX-2) generating the pro-inflammatory molecule PGE(2). The development of effective inhibitors of MPGES1 holds promise as a highly selective route for controlling inflammation. In this paper, we describe the use of backbone amide H/D exchange mass spectrometry to map the binding sites of different types of inhibitors of MPGES1. The results reveal the locations of specific inhibitor binding sites that include the GSH binding site and a hydrophobic cleft in the protein thought to accommodate the prostaglandin H-2 substrate. In the absence of three-dimensional crystal structures of the enzyme-bound inhibitors, the results provide clear physical evidence that three pharmacologically active inhibitors bind in a hydrophobic cleft composed of sections of transmembrane helices Ia, IIb, IIIb, and IVb at:the interface of subunits in the trimer. In principle, the HID exchange behavior of the protein can be used as a preliminary guide for optimization of inhibitor efficacy. Finally, a comparison of the structures and H/D exchange behavior of MPGES1 and the related enzyme MGST1 in the presence of glutathione and the inhibitor glutathione sulfonate confirms the unusual observation that two proteins from the same superfamily harbor GSH binding sites in different locations.
引用
收藏
页码:7684 / 7693
页数:10
相关论文
共 50 条
  • [41] Microsomal prostaglandin E synthase-1 (mPGES-1) prevents Fas-induced liver injury
    Yao, Lu
    Han, Chang
    Wu, Tong
    HEPATOLOGY, 2014, 60 : 720A - 720A
  • [42] Identification of Key Residues Determining Species Differences in Inhibitor Binding of Microsomal Prostaglandin E Synthase-1
    Pawelzik, Sven-Christian
    Uda, Narasimha Rao
    Spahiu, Linda
    Jegerschold, Caroline
    Stenberg, Patric
    Hebert, Hans
    Morgenstern, Ralf
    Jakobsson, Per-Johan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (38) : 29254 - 29261
  • [43] Synergistic effect of microsomal prostaglandin E synthase (MPGES)-1, MPGES-2, and COX-2 coexpression on colorectal cancer patient prognosis
    Tatsuguchi, Atsushi
    See, Tsuguhiko
    Shinji, Sciichi
    Yonezawa, Masaoki
    Wada, Ken
    Mitsui, Keigo
    Tanaka, Shu
    Fujimori, Shunji
    Gudis, Katya
    Tajiri, Takashi
    Sakamoto, Choitsu
    GASTROENTEROLOGY, 2008, 134 (04) : A444 - A444
  • [44] Effect of Estrus Synchronization on Endometrial Prostaglandin F Synthase (PGFS) and Microsomal Prostaglandin E Synthase-1 (mPGES-1) mRNA Expression in Early Pregnant Pigs
    Blitek, A.
    Waclawik, A.
    Kaczmarek, M. M.
    Kiewisz, J.
    Ziecik, A. J.
    REPRODUCTION IN DOMESTIC ANIMALS, 2008, 43 : 90 - 90
  • [45] Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke
    Lexiao Li
    Nelufar Yasmen
    Ruida Hou
    Seyoung Yang
    Jae Yeol Lee
    Jiukuan Hao
    Ying Yu
    Jianxiong Jiang
    Neurotherapeutics, 2022, 19 : 366 - 385
  • [46] Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke
    Li, Lexiao
    Yasmen, Nelufar
    Hou, Ruida
    Yang, Seyoung
    Lee, Jae Yeol
    Hao, Jiukuan
    Yu, Ying
    Jiang, Jianxiong
    NEUROTHERAPEUTICS, 2022, 19 (01) : 366 - 385
  • [47] Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions
    Li Xing
    Ravi G. Kurumbail
    Ronald B. Frazier
    Michael S. Davies
    Hideji Fujiwara
    Robin A. Weinberg
    James K. Gierse
    Nicole Caspers
    Jeffrey S. Carter
    Joseph J. McDonald
    William M. Moore
    Michael L. Vazquez
    Journal of Computer-Aided Molecular Design, 2009, 23 : 13 - 24
  • [48] Regulation of mPGES (microsomal prostaglandin e synthase) by IL-1 in human chondrocytes: Role of p38-MAPK pathway.
    Masuko-Hongo, K
    Berenbaum, F
    Humbert, L
    Salvat, C
    Goldring, MB
    Thirion, S
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S594 - S594
  • [49] Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions
    Xing, Li
    Kurumbail, Ravi G.
    Frazier, Ronald B.
    Davies, Michael S.
    Fujiwara, Hideji
    Weinberg, Robin A.
    Gierse, James K.
    Caspers, Nicole
    Carter, Jeffrey S.
    McDonald, Joseph J.
    Moore, William M.
    Vazquez, Michael L.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (01) : 13 - 24
  • [50] Microsomal prostaglandin E synthase-1 (mPGES-1) is the primary form of PGES expressed by the primate periovulatory follicle
    Duffy, DM
    Seachord, CL
    Dozier, BL
    HUMAN REPRODUCTION, 2005, 20 (06) : 1485 - 1492